| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 5010 | DFEAN |
5010.0010: 10 mg per vial 5010.0020: 20 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Precursor for [11C]FDDNP
|
||
| Due to patent related reasons we regret that we are not allowed to sell the product to the following countries: USA, Canada, Australia, Japan, Hongkong, and European Union. | ||
| Molar Mass: 279.31 | ||
| C17H14FN3 | ||
| CAS-RN not yet assigned | ||
| [18F]DFEAN: [1161260-63-4] | ||
| Reddish solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H, 19F and 13C-NMR spectra |
||
|
Chemical Name: Propanedinitrile, [1-[6-[2-fluoroethyl]amino]-2-naphthalenyl]ethylidene]- |
||
|
Synonymes: 2-{1-[6-(2-Fluoro-ethylamino)-naphthalen-2-yl]-ethylidene}-malononitrile |
||
|
Literature: 1. Barrio J. et al. Neurofibrillary tangles (NFTs) and beta-amyloid plaques (A-beta) demonstrated in vivo in Alzheimer′s disease (AD) patients. J. Cereb. Blood Flow Metab. 1999, 19, S2. |
||
| 2. Adgeppa E. D. et al. Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for beta-Amyloid plaques in Alzheimer′s Disease. J. Neurosci. 2001, 21, RC189. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1